… Chitosan has the potential to alleviate diabetic hyperglycemia by reducing hepatic
gluconeogenesis … effect of chitosan oligosaccharide (COS). COS supplementation has the …

… Chitosan oligosaccharide (COS) is an oligomer of chitosan prepared by the deacetylation of
… the beneficial effects of COS on obesity, dyslipidemia, diabetes mellitus, hyperglycemia, and …

… diabetes (T2DM) and eventually diabetic nephropathy (DN). Chitosan oligosaccharide (COS)
is an oligomer of chitosan … lipid lowering, anti-inflammation, anti-diabetes, and anti-oxidant …

Chitosan oligosaccharides (COS), hydrolysed products of chitosan, are low-molecular
weight polymers with a positive charge and good biocompatibility. COS have recently been …

… conditions, making them potential therapeutic substances for … oligosaccharide and deep-sea
water with fewer side effects An anti-obesity composition is presented, containing chitosan …

… However, effective agents for the prevention or treatment of obesity remain limited. This
study investigated the anti-obesity effect and mechanism of chitosan oligosaccharide capsules (…

… The anti-diabetic action of chitosan in this study was due to its ability to prevent the loss of β
… anti-diabetic effect of low-MW chitosan was investigated in KK-Ay mice, a genetically obese …

… Chitosan oligosaccharide (COS) provides potent anti-obesity … a potential prebiotic effect
improving gut dysbiosis and maintaining the intestinal epithelial barrier in obese and diabetic …

… chitosan (LC) with short-chain chitosan (SC) for their antiobesity effects in high-fat diet (HFD)-induced
obese … The L:A ratio is a potential predictor of metabolic syndrome and the L:A ratio…

… high polymerization degree of chitosan oligosaccharide, a moderate … chitosan oligosaccharide
exhibited a higher inhibitory effect, indicating that the higher DP is related to stronger anti-…